Insight Molecular Diagnostics Inc. Undistributed Earnings (Loss) from Discontinued Operations Available to Common Shareholders, Basic
Insight Molecular Diagnostics Inc. (IMDX) reported Undistributed Earnings (Loss) from Discontinued Operations Available to Common Shareholders, Basic of $424.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Notes › Earnings Per Share, Basic, Two Class Method
us-gaap:UndistributedEarningsLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic · last filed 2023-05-15
- Insight Molecular Diagnostics Inc. undistributed earnings (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2023-03-31 was $424.00K.
| Period end | Undistributed Earnings (Loss) from Discontinued Operations Available to Common Shareholders, Basic 3 month |
|---|---|
| 2023-03-31 | $424.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |